Oppenheimer Raises Addus HomeCare (NASDAQ:ADUS) Price Target to $150.00

Addus HomeCare (NASDAQ:ADUS) had its target price increased by Oppenheimer from $145.00 to $150.00 in a research note released on Friday morning,Benzinga reports. They currently have an outperform rating on the stock.

Other analysts have also issued reports about the stock. JMP Securities assumed coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price for the company. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. KeyCorp assumed coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Finally, Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $134.22.

Addus HomeCare Stock Up 2.8 %

Shares of ADUS stock opened at $130.62 on Friday. The company has a 50 day moving average price of $126.10 and a 200-day moving average price of $126.96. Addus HomeCare has a 52 week low of $85.94 and a 52 week high of $136.72. The firm has a market capitalization of $2.37 billion, a PE ratio of 29.89, a P/E/G ratio of 1.73 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period in the previous year, the business posted $1.03 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. Analysts anticipate that Addus HomeCare will post 4.58 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,750 shares of company stock valued at $4,930,750 over the last 90 days. 4.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds have recently modified their holdings of ADUS. Point72 Asset Management L.P. raised its stake in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares in the last quarter. Millennium Management LLC raised its stake in Addus HomeCare by 412.7% during the second quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after purchasing an additional 254,705 shares in the last quarter. Wasatch Advisors LP raised its stake in Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after purchasing an additional 110,010 shares in the last quarter. Ghisallo Capital Management LLC purchased a new stake in Addus HomeCare during the second quarter valued at $11,611,000. Finally, Principal Financial Group Inc. raised its stake in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.